ONC
BeOne Medicines Ltd
240 hedge funds and large institutions have $8.34B invested in BeOne Medicines Ltd in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 90 increasing their positions, 83 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
28% less capital invested
Capital invested by funds: $11.6B → $8.34B (-$3.23B)
42% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 48
Holders
240
Holding in Top 10
8
Calls
$36.7M
Puts
$33.2M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$21.8M | |
| 3 | +$17.5M | |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$16.5M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$13M |
Top Sellers
| 1 | -$988M | |
| 2 | -$410M | |
| 3 | -$108M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$77M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$60.8M |
